References
- Jarrott B, Vajda FJ. The current status of monoamine oxidase and its inhibitors. Med J Aust 1987; 146: 634–638
- Hodgman M, Martin T, Dean B, Krenzelok E. Severe serotonin syndrome secondary to venlafaxine and maintenance tranylcypromine therapy. J Toxicol Clin Toxicol 1995; 33: 554
- Brubacher J F, Lurin M J, Hirsch S, Hoffman R S. Serotonin syndrome from venlafaxine-tranylcypromine interaction. J Toxicol Clin Toxicol 1995; 33: 523–524
- Klysner R, Larsen J K, Sorensen P, Hyllested M, Pedersen BD. Toxic interaction of venlafaxine and isocarboxazide. Lancet 1995; 346: 1298–1299
- Phillips S D, Ringo P. Phenelzine and venlafaxine interaction. Am J Psychiatry 1995; 152: 1400–1401
- Mills KC. Serotonin syndrome. Am Fam Physician 1995; 52: 1475–1482
- Package insert. Effexor (Venlafaxine hydrochloride). Wyeth Laboratories, Philadelphia December, 1993
- Baldessarini RJ. Drugs and the treatment of psychiatric disorders depression and mania. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., JG Harriman, LE Limbird, PB Motinoff, RW Ruddon. McGraw-Hill, Hightstown, NJ 1996; 440